Insights On Critical Environments

  1. Identifying Worst-Case Locations Assessing Homogeneity Using BIs And EIs 7/27/2026

    Combine quantitative enzyme indicators, computational fluid dynamics, and traditional biological indicators to improve VPHP isolator validation and process confidence.

  2. Monitoring, Media Fills, And QC: Demonstrating Sterility Assurance At Your CDMO 2/13/2026

    CDMO guide on environmental monitoring, media fills, and QC to prove sterility assurance in aseptic manufacturing—key elements of the Contamination Control Strategy beyond facility design.

  3. Ingredients In Small Molecule Drug Production Systems 6/22/2026

    Control contamination in sourced ingredients with layered filtration: particle removal, bioburden control, and tank protection improve reliability, reduce risk, and supports consistent product quality.

  4. USP Draft Chapters On CCS: What You Need To Know 5/12/2026

    Learn why it's important to stay aligned with evolving Annex 1 expectations to support sterility assurance, regulatory compliance, and patient safety across sterile drug manufacturing operations.

  5. Lessons From FDA 483s And Warning Letters: Cleanroom Compliance 12/8/2025

    Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.

  6. 10 Practical Tips For GMP Cleanroom Contamination Monitoring 2/13/2026

    A robust cleanroom monitoring program is your best defense against contamination. Align your strategy with Annex 1 to detect risks early, protect your product, and ensure patient safety.

  7. Compressed Gas Contamination: Guidelines For Control In Aseptic Manufacturing 10/18/2024

    Explore key guidelines for preserving the purity and quality of compressed gas, with an emphasis on contaminants, monitoring, and preventive maintenance practices.

  8. Beyond Flexibility: The Strategic Value Of Single-Use In Virus Filtration 7/24/2026

    Single-use virus filtration offers key strategic benefits beyond operational convenience, enabling faster time to market, scalable manufacturing, and flexible supply chains for biopharma production.

  9. Measuring And Monitoring Environmental Surface Residues 4/1/2025

    Explore techniques like visual inspection and TOC sampling to assess surface residues as well as discover the benefits and challenges of these practical methods to achieve effective residue validation.

  10. Enhancing Quality And Environmental Monitoring Efficiency Through Paperless Sampling 9/9/2026

    At roughly 600,000 samples per year, manual EM documentation creates real compliance and operational risk. This whitepaper details how a fully integrated digital sampling system addresses both.